Literature DB >> 26724557

Beta blockers in cirrhosis: The window re-opens.

Guadalupe Garcia-Tsao1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26724557     DOI： 10.1016/j.jhep.2015.12.012

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  6 in total

1.  The Use of Nonselective Beta Blockers for Treatment of Portal Hypertension.

Authors:  Guadalupe Garcia-Tsao
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-10

Review 2.  A Historical Overview of Spontaneous Bacterial Peritonitis: From Rare to Resistant.

Authors:  Lamia Y Haque; Guadalupe Garcia-Tsao
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-10-29

3.  Beta-blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation.

Authors:  A Q Bhutta; G Garcia-Tsao; K R Reddy; P Tandon; F Wong; J G O'Leary; C Acharya; D Banerjee; J G Abraldes; T M Jones; J Shaw; Y Deng; M Ciarleglio; J S Bajaj
Journal:  Aliment Pharmacol Ther       Date:  2017-10-09       Impact factor: 8.171

4.  Does pressure cause liver cirrhosis? The sinusoidal pressure hypothesis.

Authors:  Sebastian Mueller
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742

Review 5.  Management of acute variceal hemorrhage.

Authors:  Alberto Zanetto; Guadalupe Garcia-Tsao
Journal:  F1000Res       Date:  2019-06-25

6.  α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin.

Authors:  Ute A Schwinghammer; Magda M Melkonyan; Lilit Hunanyan; Roman Tremmel; Ralf Weiskirchen; Erawan Borkham-Kamphorst; Elke Schaeffeler; Torgom Seferyan; Wolfgang Mikulits; Konstantin Yenkoyan; Matthias Schwab; Lusine Danielyan
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.